Please login to the form below
FDA scrutiny of alirocumab hits Regeneron and Sanofi
Regulator to assess neurocognitive effects of cholesterol drug
EMA to restrict use of domperidone and diacerein
Regulator's pharmacovigilance advisors also want insomnia drug zolpidem's labelling tightened up
New data puts Jakafi on course for blockbuster status
Novartis/Incyte drug meets targets in blood cancer trial
Pfizer recalls depression drug in US
Wrong medicine found in bottle of Effexor XR
J&J gets EU green light for novel TB drug
Sirturo approved to treat multidrug resistant form of the disease
Novartis' dermatology plans advance with Xolair approval
Green light for use in chronic spontaneous urticaria
Diabetes awards programme launches
QiC Diabetes 2014 premiered at Diabetes UK conference
INC Research acquires Middle Eastern CRO
Purchase of MEK Consulting expands its geographic footprint
BMS' novel HIV drug clears phase II trial
Entry inhibitor BMS-660368 moves closer to first-in-class approval
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
-
Use data responsiblyIt’s imperative that opening up clinical trial data doesn’t compromise patient safety
-
Pharma’s four options for innovationOnly genuinely creative companies will profit from the future
-
Lilly/Boehringer's empagliflozin faces US approval delayFDA cites manufacturing issues with the new diabetes drug
-
UDG buys KnowledgePoint360’s comms businessDeal is worth $144m
-
Edelman extends PR contract with Leo PharmaWill continue to work together in Germany
-
Eisai and Biogen partner on Alzheimer’sWill co-develop two drug candidates
-
Generic for Lilly's Evista in US 'within a month'Teva to launch copy of osteoporosis drug
-
NICE relents and backs Pfizer's InlytaRecommends drug to treat advanced kidney cancer on NHS in England
-
NHS promotes better drug understanding‘My Medicines, My Health’ kicks off in north east England
Latest appointments
-
Oxford Pharmascience adds to boardJohn Goddard is former head of group strategic planning and business at AstraZeneca
-
Stallergenes appoints Christian Chavy CEOHe will replace Roberto Gradnik at the end of this month
-
New VP for Merz North AmericaGregory Bass to lead market access and reimbursement strategy
-
Vansen Pharma appoints new president and CEO
Ahmad Doroudian was CEO of Merus Labs International
-
Novasep appoints board chairmanCEO Michel Spagnol takes on dual role
Featured jobs
- Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.
- Salary up to £65,000
- Client Director, Healthcare, Dublin
- Competitive salary, plus benefits
- Account Associate
- On application
- Account Director – PR Healthcare
- Excellent salary and package
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Business Development Director
- Competitive Salary Offered
- Account Director - Medical Education
- Competitive + excellent benefits
- Account Director- Healthcare
- Highly Competitive Salary
- Planning Director
- Circa £100,000 with Extensive Package
- Account Manager / (Senior) Analyst – Market Access
- Up to £45,000 plus bonus
- Account Director
- up to 60k
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
Subscribe to our email news alerts
PMHub
Genetic Digital
Genetic Digital specialises in identifying, creating and promoting the most valuable digital marketing assets that will enable pharmaceutical brands to...
Latest intelligence
- NICE and ‘ultra orphans’
- NICE and its processes for ‘highly specialised therapies’...
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
Quick links
